Philippine drug war
The Philippine Drug War, also known as the War on Drugs in the Philippines, is an ongoing government-led initiative that aims to eliminate drug use and drug trafficking in the country. Initiated by President Rodrigo Duterte upon his assumption of office in 2016, the campaign has been marked by a high number of deaths and human rights controversies.
Background[edit]
The drug problem in the Philippines has been a persistent issue for decades. Prior to the drug war, the country was considered a major transit point and consumer of illegal drugs, particularly methamphetamine (locally known as shabu) and marijuana. The Philippine Drug Enforcement Agency (PDEA) has been the primary agency tasked with addressing this issue.
Implementation[edit]
Upon his election, President Duterte launched an aggressive campaign against illegal drugs. The campaign involves large-scale police operations, known as Oplan Tokhang, where suspected drug users and dealers are urged to surrender. However, these operations have been criticized for their violent nature, often resulting in the deaths of suspects.
Controversies and Criticisms[edit]
The Philippine Drug War has been heavily criticized by various local and international groups, including Human Rights Watch and the United Nations, for alleged human rights abuses. Critics argue that the campaign has resulted in extrajudicial killings and has disproportionately targeted poor communities. The government, however, maintains that the deaths are the result of legitimate police operations.
Impact[edit]
The impact of the drug war on Philippine society has been significant. While the government claims that the campaign has resulted in a decrease in drug-related crimes, critics argue that it has only resulted in a climate of fear and impunity. The drug war has also strained the country's relations with several international bodies and countries.
See Also[edit]
References[edit]
-
Rodrigo Duterte showing diagram of drug trade network
-
Philippine National Police seal
-
ICAD PH logo
-
Philippine Drug Enforcement Agency (PDEA)
-
National Bureau of Investigation (NBI)
-
Seal of the Armed Forces of the Philippines
-
Bureau of Customs
-
Department of Justice (DOJ)
-
Anti-Money Laundering Council
-
Philippine Coast Guard (PCG)
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian